Fortescue 1st Half Net Profit Up 41%, Raises Dividend
By Rhiannon Hoyle
Fortescue on Thursday reported a 41% rise in first-half net profit and raised its midyear payout to shareholders, reflecting an increase in the price it fetched for its iron ore.
The world's fourth-largest iron-ore producer said it made a net profit of US$3.34 billion in the six months through December, up from US$2.37 billion a year earlier.
Directors declared an interim dividend of 1.08 Australian dollars (US$0.71) a share, compared to 75 Australian cents a year ago.
Underlying earnings before interest, tax, depreciation and amortization, or Ebitda, increased by 36% to US$5.91 billion, the miner said.
Fortescue, which makes its money running iron-ore pits in remote northwest Australia, benefited from higher prices for the commodity used to make steel. The company said its average price for the half-year was roughly US$108 a metric ton versus about US$87 a ton a year earlier.
Write to Rhiannon Hoyle at rhiannon.hoyle@wsj.com
Corrections & Amplifications
This item was corrected at 2303 GMT to clarify that Fortescue reported its half-year earnings on Thursday, not on Wednesday.
(END) Dow Jones Newswires
February 21, 2024 18:11 ET (23:11 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
What’s Happening in the Markets This Week
-
4 Top Dividend-Paying REIT Stock Picks
-
After Earnings, Is Netflix Stock a Buy, a Sell, or Fairly Valued?
-
P-CAPE: A Better Way for Investors to Estimate Future Returns
-
Which Stocks Have Driven the Stealth Large-Value Rally?
-
Forecasts for Q2 GDP Report Show a Healthy but Slowing Economy
-
5 Stocks to Buy as the Market Rally Broadens
-
4 Top US Travel Stock Picks
-
How Do Interest Rates Affect Stock Market Returns?
-
American Airlines Earnings: Ticket Distribution Misstep Affected Results
-
Going Into Earnings, Is Albemarle Stock a Buy, a Sell, or Fairly Valued?
-
3 Top Cybersecurity Stock Picks for Long-Term Investors
-
AbbVie Earnings: Firm Sees Strong Next-Generation Immunology Drugs Sales
-
Ford Earnings: Warranty Problems on Older Vehicles Slam Results
-
ServiceNow Earnings: Operating on a Higher Plane Within Enterprise Software